Citigroup’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-43,503
| Closed | -$64K | – | 5749 |
|
|
2016
Q1 | $64K | Buy |
43,503
+24,933
| +134% | +$36.7K | ﹤0.01% | 4176 |
|
|
2015
Q4 | $59K | Buy |
18,570
+14,543
| +361% | +$46.2K | ﹤0.01% | 3967 |
|
|
2015
Q3 | $25K | Sell |
4,027
-161
| -4% | -$1K | ﹤0.01% | 3948 |
|
|
2015
Q2 | $42K | Buy |
4,188
+388
| +10% | +$3.89K | ﹤0.01% | 3859 |
|
|
2015
Q1 | $28K | Sell |
3,800
-4,854
| -56% | -$35.8K | ﹤0.01% | 4215 |
|
|
2014
Q4 | $46K | Buy |
8,654
+4,848
| +127% | +$25.8K | ﹤0.01% | 4147 |
|
|
2014
Q3 | $19K | Buy |
3,806
+1,526
| +67% | +$7.62K | ﹤0.01% | 4321 |
|
|
2014
Q2 | $15K | Sell |
2,280
-1,649
| -42% | -$10.8K | ﹤0.01% | 4369 |
|
|
2014
Q1 | $28K | Sell |
3,929
-2,237
| -36% | -$15.9K | ﹤0.01% | 4326 |
|
|
2013
Q4 | $23K | Buy |
+6,166
| New | +$23K | ﹤0.01% | 4550 |
|